About GIBSON ONCOLOGY, LLC
Gibson Oncology is a biotechnology company focused on developing innovative therapies for brain cancer, currently conducting a phase II trial with LMP744 in recurrent glioblastoma under the NIH. The trial has FDA Orphan Drug Status and may qualify as a Registration Trial based on results.
Conducting phase II clinical trials in recurrent glioblastomaDeveloping drugs with c-Myc and Topo 1 activityCreating compounds that cross the blood-brain barrier (BBB)Utilizing strong PDX data in GBMObtaining FDA Orphan Drug Status for LMP744
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to GIBSON ONCOLOGY, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.